314 related articles for article (PubMed ID: 18641049)
21. Valsartan regulates the interaction of angiotensin II type 1 receptor and endothelial nitric oxide synthase via Src/PI3K/Akt signalling.
Su KH; Tsai JY; Kou YR; Chiang AN; Hsiao SH; Wu YL; Hou HH; Pan CC; Shyue SK; Lee TS
Cardiovasc Res; 2009 Jun; 82(3):468-75. PubMed ID: 19307231
[TBL] [Abstract][Full Text] [Related]
22. Helium-induced early preconditioning and postconditioning are abolished in obese Zucker rats in vivo.
Huhn R; Heinen A; Weber NC; Kerindongo RP; Oei GT; Hollmann MW; Schlack W; Preckel B
J Pharmacol Exp Ther; 2009 May; 329(2):600-7. PubMed ID: 19244549
[TBL] [Abstract][Full Text] [Related]
23. Chronic hyperleptinemia induces resistance to acute natriuretic and NO-mimetic effects of leptin.
Bełtowski J; Wójcicka G; Jamroz-Wiśniewska A; Wojtak A
Peptides; 2010 Jan; 31(1):155-63. PubMed ID: 19854228
[TBL] [Abstract][Full Text] [Related]
24. Long-term effects of rapamycin treatment on insulin mediated phosphorylation of Akt/PKB and glycogen synthase activity.
Varma S; Shrivastav A; Changela S; Khandelwal RL
Exp Cell Res; 2008 Apr; 314(6):1281-91. PubMed ID: 18261725
[TBL] [Abstract][Full Text] [Related]
25. Statin-dependent suppression of the Akt/mammalian target of rapamycin signaling cascade and programmed cell death 4 up-regulation in renal cell carcinoma.
Woodard J; Sassano A; Hay N; Platanias LC
Clin Cancer Res; 2008 Jul; 14(14):4640-9. PubMed ID: 18628479
[TBL] [Abstract][Full Text] [Related]
26. Ankyrin repeat and suppressor of cytokine signaling (SOCS) box-containing protein (ASB) 15 alters differentiation of mouse C2C12 myoblasts and phosphorylation of mitogen-activated protein kinase and Akt.
McDaneld TG; Spurlock DM
J Anim Sci; 2008 Nov; 86(11):2897-902. PubMed ID: 18641171
[TBL] [Abstract][Full Text] [Related]
27. Chronic inhibition of mammalian target of rapamycin signaling downregulates insulin receptor substrates 1 and 2 and AKT activation: A crossroad between cancer and diabetes?
Di Paolo S; Teutonico A; Leogrande D; Capobianco C; Schena PF
J Am Soc Nephrol; 2006 Aug; 17(8):2236-44. PubMed ID: 16807405
[TBL] [Abstract][Full Text] [Related]
28. Critical and diverse involvement of Akt/mammalian target of rapamycin signaling in human lung carcinomas.
Dobashi Y; Suzuki S; Matsubara H; Kimura M; Endo S; Ooi A
Cancer; 2009 Jan; 115(1):107-18. PubMed ID: 19090006
[TBL] [Abstract][Full Text] [Related]
29. Antimyeloma activity of the orally bioavailable dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235.
McMillin DW; Ooi M; Delmore J; Negri J; Hayden P; Mitsiades N; Jakubikova J; Maira SM; Garcia-Echeverria C; Schlossman R; Munshi NC; Richardson PG; Anderson KC; Mitsiades CS
Cancer Res; 2009 Jul; 69(14):5835-42. PubMed ID: 19584292
[TBL] [Abstract][Full Text] [Related]
30. Long-chain n-3 polyunsaturated fatty acids dissociate phosphorylation of Akt from phosphatidylinositol 3'-kinase activity in rats.
Le Foll C; Corporeau C; Le Guen V; Gouygou JP; Bergé JP; Delarue J
Am J Physiol Endocrinol Metab; 2007 Apr; 292(4):E1223-30. PubMed ID: 17179391
[TBL] [Abstract][Full Text] [Related]
31. Both Wnt and mTOR signaling pathways are involved in insulin-stimulated proto-oncogene expression in intestinal cells.
Sun J; Jin T
Cell Signal; 2008 Jan; 20(1):219-29. PubMed ID: 17993259
[TBL] [Abstract][Full Text] [Related]
32. [Aortic endothelium-dependent vasodilation function and PI3K-, PKB-, eNOS mRNA expressions in insulin-resistant and type 2 diabetic rats].
Wu J; Lei MX; Liu L; Xie XY
Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Mar; 35(3):265-70. PubMed ID: 17582297
[TBL] [Abstract][Full Text] [Related]
33. T-cadherin attenuates insulin-dependent signalling, eNOS activation, and angiogenesis in vascular endothelial cells.
Philippova M; Joshi MB; Pfaff D; Kyriakakis E; Maslova K; Erne P; Resink TJ
Cardiovasc Res; 2012 Mar; 93(3):498-507. PubMed ID: 22235028
[TBL] [Abstract][Full Text] [Related]
34. Selective insulin resistance affecting nitric oxide release but not plasminogen activator inhibitor-1 synthesis in fibroblasts from insulin-resistant individuals.
Pandolfi A; Solini A; Pellegrini G; Mincione G; Di Silvestre S; Chiozzi P; Giardinelli A; Di Marcantonio MC; Piccirelli A; Capani F; Consoli A
Arterioscler Thromb Vasc Biol; 2005 Nov; 25(11):2392-7. PubMed ID: 16151016
[TBL] [Abstract][Full Text] [Related]
35. PI3K/Akt/mTOR signaling regulates glutamate transporter 1 in astrocytes.
Wu X; Kihara T; Akaike A; Niidome T; Sugimoto H
Biochem Biophys Res Commun; 2010 Mar; 393(3):514-8. PubMed ID: 20152809
[TBL] [Abstract][Full Text] [Related]
36. Glimepiride upregulates eNOS activity and inhibits cytokine-induced NF-kappaB activation through a phosphoinoside 3-kinase-Akt-dependent pathway.
Jojima T; Suzuki K; Hirama N; Uchida K; Hattori Y
Diabetes Obes Metab; 2009 Feb; 11(2):143-9. PubMed ID: 18564176
[TBL] [Abstract][Full Text] [Related]
37. Interference between insulin and estradiol signaling pathways in the regulation of cardiac eNOS and Na(+)/K(+)-ATPase.
Koricanac G; Tepavcevic S; Zakula Z; Milosavljevic T; Stojiljkovic M; Isenovic ER
Eur J Pharmacol; 2011 Mar; 655(1-3):23-30. PubMed ID: 21272573
[TBL] [Abstract][Full Text] [Related]
38. Chronic selective glycogen synthase kinase-3 inhibition enhances glucose disposal and muscle insulin action in prediabetic obese Zucker rats.
Dokken BB; Henriksen EJ
Am J Physiol Endocrinol Metab; 2006 Aug; 291(2):E207-13. PubMed ID: 16478771
[TBL] [Abstract][Full Text] [Related]
39. Effect of a 2-day very low-energy diet on skeletal muscle insulin sensitivity in obese type 2 diabetic patients on insulin therapy.
Jazet IM; Ouwens DM; Schaart G; Pijl H; Keizer H; Maassen JA; Meinders AE
Metabolism; 2005 Dec; 54(12):1669-78. PubMed ID: 16311102
[TBL] [Abstract][Full Text] [Related]
40. Involvement of phosphoinositide 3-kinase and Akt in the induction of muscle protein degradation by proteolysis-inducing factor.
Russell ST; Eley HL; Wyke SM; Tisdale MJ
Biochem J; 2008 Feb; 409(3):751-9. PubMed ID: 17961125
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
